A new device is allowing
University of Cincinnati cardiologists to recover the hearts of patients with severe heart disease by taking over the pumping action during cardiac procedures.
According to
UC HealthNews, the Impella 2.5 is a minimally invasive catheter designed to pump blood to the aorta and reduce the heart's workload and oxygen consumption.
When implanted, the device uses a miniature pump to push 2.5 liters of freshly oxygenated blood from the left ventricle of the heart into the aorta, vastly eliminating stress for patients with limited function.
The Impella 2.5, which has already been approved by the
U.S. Food and Drug Administration, is being tested against the traditional balloon pump in the PROTECT II clinical trial to see which is more beneficial to patients.
Read the full article
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.